CRBU
Caribou Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.30
−0.76%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.29
- Revenue estimate
- $2.2M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.32
- Revenue actual
- $1.5M
- Revenue estimate
- $2.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +18.4%
- Revenue beats (12Q)
- 6
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.32 | -$0.24 | Beat 25.93% | $1.5M |
| May 7, 2026 | -$0.33 | -$0.26 | Beat 21.21% | $2.4M |
| Mar 5, 2026 | -$0.31 | -$0.28 | Beat 9.68% | $3.9M |
| Nov 12, 2025 | -$0.36 | -$0.30 | Beat 16.67% | $2.2M |
| Aug 12, 2025 | -$0.40 | -$0.35 | Beat 12.50% | $2.7M |
| May 8, 2025 | -$0.43 | -$0.43 | In line | $2.4M |
| Mar 10, 2025 | -$0.40 | -$0.39 | Beat 2.50% | $2.1M |
| Mar 11, 2024 | -$0.22 | -$0.39 | Miss -77.27% | $3.6M |
| Mar 9, 2023 | -$0.47 | -$0.44 | Beat 6.38% | $3.7M |
| Mar 21, 2022 | -$0.34 | -$0.34 | In line | $2.6M |
| Sep 2, 2021 | $0.42 | -$1.55 | Miss -469.05% | $1.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026